Kaposi's sarcoma-associated herpesvirus oncoprotein K13 protects against B cell receptor-induced growth arrest and apoptosis through NF-κB activation

Journal of Virology

Volumn 87, Issue 4, 2013, Pages 2242-2252

  Graham, Ciaren ^a   Matta, Hittu ^a   Yang, Yanqiang ^b   Yi, Han ^a   Suo, Yulan ^a   Tolani, Bhairavi ^a   Chaudhary, Preet M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; B LYMPHOCYTE RECEPTOR; CYCLIN DEPENDENT KINASE INHIBITOR 1B; FLICE INHIBITORY PROTEIN; FLICE INHIBITORY PROTEIN K13; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN M ANTIBODY; MYC PROTEIN; ONCOPROTEIN; PROTEIN MCL 1; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG; VIRAL FLICE INHIBITORY PROTEIN E8;

AMINO ACID SUBSTITUTION; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL LINE; CELL PROTECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; HUMAN HERPESVIRUS 8; LYMPHOPROLIFERATIVE DISEASE; MUTANT; PHARMACOLOGICAL BLOCKING; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SUBUNIT; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY; UPREGULATION;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL LINE; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; MICE; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSCRIPTION FACTOR RELB; VIRAL PROTEINS;

EID: 84873827905     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01393-12     Document Type: Article

References (47)

1. Niiro H, Clark EA. 2002. Regulation of B-cell fate by antigen-receptor signals. Nat. Rev. Immunol. 2:945-956.
2. Eeva J, Pelkonen J. 2004. Mechanisms of B cell receptor induced apoptosis. Apoptosis 9:525-531.
3. Gerondakis S, Siebenlist U. 2010. Roles of the NF-κB pathway in lymphocyte development and function. Cold Spring Harbor Perspect. Biol. 2:a000182.
4. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
5. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, Knowles DM. 1996. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88:645- 656.
6. Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, D'Agay MF, Clauvel JP, Raphael M, Degos L, Sigaux F. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276 -1280.
7. Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N, Meignin V, Oksenhendler E, Boshoff C, Isaacson PG. 2001. Kaposi sarcomaassociated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 97:2130 -2136.
8. Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C. 2000. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95:1406 -1412.
9. Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N, van Marck E, Salmon D, Gorin I, Escande JP, Weiss RA, Alitalo K, Boshoff C. 1999. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc. Natl. Acad. Sci. U. S. A. 96:4546-4551.
10. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J. 1997. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521.
11. Chaudhary PM, Jasmin A, Eby MT, Hood L. 1999. Modulation of the NF-kappa B pathway by virally encoded death effector domainscontaining proteins. Oncogene 18:5738 -5746.
12. Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C, Collins M. 2003. KSHV vFLIP binds to IKK-κ to activate IKK. J. Cell Sci. 116:3721-3728.
13. Liu L, Eby MT, Rathore N, Sinha SK, Kumar A, Chaudhary PM. 2002. The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Iκ B kinase complex. J. Biol. Chem. 277:13745-13751.
14. Matta H, Chaudhary PM. 2004. Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domainlike IL-1 beta-converting enzyme inhibitory protein (vFLIP). Proc. Natl. Acad. Sci. U. S. A. 101:9399 -9404.
15. Chugh P, Matta H, Schamus S, Zachariah S, Kumar A, Richardson JA, Smith AL, Chaudhary PM. 2005. Constitutive NF-κB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 102: 12885-12890.
16. Guasparri I, Keller SA, Cesarman E. 2004. KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199:993-1003.
17. Matta H, Surabhi RM, Zhao J, Punj V, Sun Q, Schamus S, Mazzacurati L, Chaudhary PM. 2007. Induction of spindle cell morphology in human vascular endothelial cells by human herpesvirus 8-encoded viral FLICE inhibitory protein K13. Oncogene 26:1656 -1660.
18. Sun Q, Matta H, Chaudhary PM. 2003. The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-κB activation. Blood 101:1956 -1961.
19. Sun Q, Matta H, Lu G, Chaudhary PM. 2006. Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-κB activation. Oncogene 25:2717-2726.
20. Sun Q, Zachariah S, Chaudhary PM. 2003. The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-κB activation. J. Biol. Chem. 278:52437-52445.
21. Benhamou LE, Cazenave PA, Sarthou P. 1990. Anti-immunoglobulins induce death by apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 20:1405-1407.
22. Matta H, Mazzacurati L, Schamus S, Yang T, Sun Q, Chaudhary PM. 2007. Kaposi's sarcoma-associated herpesvirus (KSHV) oncoprotein K13 bypasses TRAFs and directly interacts with the IκB kinase complex to selectively activate NF-κB without JNK activation. J. Biol. Chem. 282: 24858-24865.
23. Dong X, Craig T, Xing N, Bachman LA, Paya CV, Weih F, McKean DJ, Kumar R, Griffin MD. 2003. Direct transcriptional regulation of RelB by 1α,25-dihydroxyvitamin D3 and its analogs. J. Biol. Chem. 278:49378-49385.
24. Yang Y, Groshong JS, Matta H, Gopalakrishnan R, Yi H, Chaudhary PM. 2011. Constitutive NF-κB activation confers interleukin 6 (IL6) independence and resistance to dexamethasone and Janus kinase inhibitor INCB018424 in murine plasmacytoma cells. J. Biol. Chem. 286:27988-27997.
25. Matta H, Punj V, Schamus S, Mazzacurati L, Chen AM, Song R, Yang T, Chaudhary PM. 2008. A nuclear role for Kaposi's sarcoma-associated herpesvirus-encoded K13 protein in gene regulation. Oncogene 27:5243-5253.
26. Zhao J, Punj V, Matta H, Mazzacurati L, Schamus S, Yang Y, Yang T, Hong Y, Chaudhary PM. 2007. K13 blocks KSHV lytic replication and deregulates vIL6 and hIL6 Expression: a model of lytic replication induced clonal selection in viral oncogenesis. PLoS One 2:e1067.
27. Punj V, Matta H, Schamus S, Yang T, Chang Y, Chaudhary PM. 2009. Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-κB activation. Blood 113:5660 -5668.
28. Schauer SL, Bellas RE, Sonenshein GE. 1998. Dominant signals leading to inhibitor kappaB protein degradation mediate CD40 ligand rescue of WEHI 231 immature B cells from receptor-mediated apoptosis. J. Immunol. 160:4398-4405.
29. Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, FitzGerald MJ, Rothstein TL, Sherr DH, Sonenshein GE. 1996. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J. 15:4682- 4690.
30. Bren GD, Solan NJ, Miyoshi H, Pennington KN, Pobst LJ, Paya CV. 2001. Transcription of the RelB gene is regulated by NF-κB. Oncogene 20:7722-7733.
31. Mineva ND, Rothstein TL, Meyers JA, Lerner A, Sonenshein GE. 2007. CD40 ligand-mediated activation of the de novo RelB NF-κB synthesis pathway in transformed B cells promotes rescue from apoptosis. J. Biol. Chem. 282:17475-17485.
32. Wu M, Arsura M, Bellas RE, FitzGerald MJ, Lee H, Schauer SL, Sherr DH, Sonenshein GE. 1996. Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells. Mol. Cell. Biol. 16:5015-5025.
33. Wu M, Bellas RE, Shen J, Yang W, Sonenshein GE. 1999. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells. J. Immunol. 163:6530-6535.
34. Yang W, Shen J, Wu M, Arsura M, FitzGerald M, Suldan Z, Kim DW, Hofmann CS, Pianetti S, Romieu-Mourez R, Freedman LP, Sonenshein GE. 2001. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc. Oncogene 20:1688 -1702.
35. Lee H, Arsura M, Wu M, Duyao M, Buckler AJ, Sonenshein GE. 1995. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line. J. Exp. Med. 181:1169 -1177.
36. Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS. 2011. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146:904 -917.
37. Herzog S, Reth M, Jumaa H. 2009. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat. Rev. Immunol. 9:195-205.
38. Eeva J, Nuutinen U, Ropponen A, Mättö M, Eray M, Pellinen R, Wahlfors J, Pelkonen J. 2009. Feedback regulation of mitochondria by caspase-9 in the B cell receptor-mediated apoptosis. Scand. J. Immunol. 70:574 -583.
39. Vrzalikova K, Vockerodt M, Leonard S, Bell A, Wei W, Schrader A, Wright KL, Kube D, Rowe M, Woodman CB, Murray PG. 2011. Down-regulation of BLIMP1κ by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas. Blood 117:5907-5917.
40. Young LS, Dawson CW, Eliopoulos AG. 2000. The expression and function of Epstein-Barr virus encoded latent genes. Mol. Pathol. 53:238- 247.
41. Madureira PA, Matos P, Soeiro I, Dixon LK, Simas JP, Lam EW-F. 2005. Murine κ-herpesvirus 68 latency protein M2 binds to Vav signaling proteins and inhibits B-cell receptor-induced cell cycle arrest and apoptosis in WEHI-231 B cells. J. Biol. Chem. 280:37310 -37318.
42. Ballon G, Chen K, Perez R, Tam W, Cesarman E. 2011. Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice. J. Clin. Invest. 121:1141-1153.
43. Bower M, Newsom-Davis T, Naresh K, Merchant S, Lee B, Gazzard B, Stebbing J, Nelson M. 2011. Clinical features and outcome in HIVassociated multicentric Castleman's disease. J. Clin. Oncol. 29:2481-2486.
44. Parravicini C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, Chang Y. 1997. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am. J. Pathol. 151:1517-1522.
45. Waterston A, Bower M. 2004. Fifty years of multicentric Castleman's disease. Acta Oncol. 43:698 -704.
46. Hassman LM, Ellison TJ, Kedes DH. 2011. KSHV infects a subset of human tonsillar B cells, driving proliferation and plasmablast differentiation. J. Clin. Invest. 121:752-768.
47. Ahmad A, Groshong JS, Matta H, Schamus S, Punj V, Robinson LJ, Gill PS, Chaudhary PM. 2010. Kaposi's sarcoma associated herpesvirusencoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice. Cancer Biol. Ther. 10:1033-1040.